Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$1.75 USD
-0.05 (-2.78%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/15/24 |
---|---|
Current Quarter | -0.03 |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.10 |
Next Year | -0.13 |
EPS (TTM) | -0.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 2.06M | 2.09M | 1.43M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.03 | -0.03 | -0.10 | -0.13 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.02 | NA | -0.12 | -0.14 |
High Estimate | -0.02 | -0.02 | -0.08 | -0.09 |
Low Estimate | -0.03 | -0.03 | -0.12 | -0.16 |
Year ago EPS | 0.00 | -0.04 | -0.14 | -0.10 |
Year over Year Growth Est. | NA | 25.00% | 28.57% | -30.00% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.03 | -0.03 | -0.10 | -0.13 |
7 Days Ago | -0.03 | -0.03 | -0.09 | -0.13 |
30 Days Ago | -0.03 | -0.03 | -0.09 | -0.13 |
60 Days Ago | -0.04 | -0.03 | -0.12 | -0.12 |
90 Days Ago | -0.04 | -0.03 | -0.12 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.03 | -0.12 | -0.14 |
Zacks Consensus Estimate | -0.03 | -0.03 | -0.10 | -0.13 |
Earnings ESP | 0.00% | 0.00% | -20.00% | -7.69% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | -0.04 | -0.04 | 0.00 | NA |
Estimate | NA | -0.04 | -0.03 | -0.01 | NA |
Difference | NA | 0.00 | -0.01 | 0.01 | 0.00 |
Surprise | NA | 0.00% | -33.33% | 100.00% | 22.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more